Aclaris Therapeutics, Inc. (ACRS) at a glance

Aclaris Therapeutics, Inc. (ACRS) is a small-cap Healthcare company. It trades at $6.01, with a 6.9% profit margin and revenue growth of 37.2%. It does not pay a dividend. Vestovix scores it 65/100 overall. Its strongest dimension is Growth (88/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$6.02

Market cap

$603.3M

P/E ratio

n/a

Dividend yield

None

Beta

0.80

52-week range

$1.74 to $6.60